At Ascot Pharmaceutical Ltd, we are dedicated to developing innovative therapies that improve the lives of patients around the world. We believe that advancing healthcare requires high-quality, independent clinical research that addresses meaningful medical and scientific questions within our key therapeutic areas.
An Investigator-Initiated Research (IIR) study is an unsolicited request for funding and/or material support (such as study drug supply) submitted by an external investigator seeking to conduct an independent scientific investigation.
An IIR is conceived, designed, initiated, conducted, analysed, and reported entirely by the investigator — an experienced and qualified research professional who is not an employee, contractor, or agent of Ascot Pharmaceutical Ltd.
To learn more about the therapeutic areas we support, please visit our Therapies section.
Only institutions or organisations are eligible to receive IIR support from Ascot Pharmaceutical Ltd — individuals are not eligible to apply directly.
Healthcare Professionals (HCPs) serving as Principal Investigators or Co-Investigators, along with their associated institutions, will undergo a screening process to confirm there are no debarments or exclusions before participation is approved.
If you are an investigator interested in submitting an Investigator-Initiated Research proposal, please use the application link below to begin your submission process.
